A regression model for % recovery was developed and its adequacy was evaluated.
The SSD adequacy was evaluated by equalizing the available SSD and the demanded SSD and by identifying the zones where the sightline is obstructed by the median width.
Model adequacy was evaluated by comparing the predictions to a base case model in which the dependence of the reaction rate on the nonuniformity of the surface was rigorously taken into account.
Model adequacy was evaluated by χ² tests.
Nutritional adequacy was evaluated based on measurements of blood concentrations of albumin, amino acids, retinol binding protein (RBP), and erythrocyte lipid profiles.
PD adequacy was evaluated every 6 months using Baxter PD Adequest 2.0 software (Baxter Healthcare Corporation, Deerfield, IL, USA), and the averages of these parameters, including the total Kt/V, residual Kt/V, total clearance of creatinine (Ccr), residual Ccr and normalized protein catabolic rate (nPCR), were obtained.
Reporting adequacy was evaluated using an instrument that uses five criteria to identify potential causes of biases [ 9, 10]: i) Formation of study groups-allocation of subjects between the control and intervention groups, ii) Unit of allocation and analysis, iii) Baseline differences between study groups, iv) Type of outcome measure, and v) Completeness of follow-up.
The adequacy of fit is evaluated using multiple fit statistics and their ideal values are shown at the bottom of summary fit Table 1 [ 39].> Stochastic ordering of items is evaluated through the fit of data to the model.
This study sought to assess the prognostic value of the kinetics of procalcitonin (PCT), C-reactive protein (CRP) and clinical scores (clinical pulmonary infection score (CPIS), Sequential Organ Failure Assessment (SOFA)) in the outcome of ventilator-associated pneumonia (VAP) at an early time point, when adequacy of antimicrobial treatment is evaluated.
We undertook a study to assess the prognostic value of the kinetics of PCT, C-reactive protein (CRP), and the clinical scores clinical pulmonary infection score (CPIS) [ 20], Sequential Organ Failure Assessment (SOFA) [ 21], and Acute Physiology and Chronic Health Evaluation (APACHE) II [ 22], in the outcome of VAP at an early time point, when adequacy of antimicrobial treatment is evaluated.
